Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Leveling Effect01:29

Leveling Effect

In acid-base chemistry, the leveling effect refers to the limitation imposed by the solvent on the strength of acids and bases in solution. When a base stronger than the solvent's conjugate base is used, it deprotonates the solvent until the base is entirely consumed, making it ineffective against weaker acids. Conversely, an acid stronger than the solvent's conjugate acid protonates the solvent until the acid is depleted, rendering it ineffective against weaker bases. Essentially, the solvent...
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles in drug...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrostatic Control of Macrocyclization Reactions within Nanospaces.

Journal of the American Chemical Society·2019
Same author

Solvent and α-secondary kinetic isotope effects on β-glucosidase.

Biochimica et biophysica acta·2015
Same author

Reactive thioglucoside substrates for β-glucosidase.

Archives of biochemistry and biophysics·2013
Same author

Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.

The Journal of investigative dermatology·2013
Same author

Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition.

Chembiochem : a European journal of chemical biology·2012
Same author

Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.

Proceedings of the National Academy of Sciences of the United States of America·2011

Related Experiment Video

Updated: Jul 10, 2026

Elucidating β-1,3-Glucanase and Peroxidase Physicochemical Properties of Wheat Cell Wall Defense Mechanism Against Diuraphis noxia Infestation
10:26

Elucidating β-1,3-Glucanase and Peroxidase Physicochemical Properties of Wheat Cell Wall Defense Mechanism Against Diuraphis noxia Infestation

Published on: July 26, 2024

Salt effects on beta-glucosidase: pH-profile narrowing.

Erin M Bowers1, Lindsey O Ragland, Larry D Byers

  • 1Department of Chemistry, Tulane University, New Orleans, LA 70118, USA.

Biochimica Et Biophysica Acta
|November 14, 2007
PubMed
Summary

Salts inhibit sweet almond beta-glucosidase activity primarily by shifting the enzyme's pK(a) values, not by affecting its intrinsic catalytic rate. This salt-induced pK(a) shift influences the enzyme's pH profile and catalytic efficiency.

More Related Videos

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
09:07

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases

Published on: December 23, 2022

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
13:35

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jul 10, 2026

Elucidating β-1,3-Glucanase and Peroxidase Physicochemical Properties of Wheat Cell Wall Defense Mechanism Against Diuraphis noxia Infestation
10:26

Elucidating β-1,3-Glucanase and Peroxidase Physicochemical Properties of Wheat Cell Wall Defense Mechanism Against Diuraphis noxia Infestation

Published on: July 26, 2024

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
09:07

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases

Published on: December 23, 2022

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
13:35

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota

Published on: May 23, 2025

Area of Science:

  • Biochemistry
  • Enzymology

Background:

  • Sweet almond beta-glucosidase activity is modulated by salt concentrations.
  • Enzyme activity is dependent on the protonation states of catalytic residues.

Purpose of the Study:

  • To investigate the inhibitory effects of various salts on sweet almond beta-glucosidase.
  • To elucidate the mechanism by which salts affect enzyme activity, specifically focusing on pK(a) shifts and reverse protonation.

Main Methods:

  • Assessed inhibition of beta-glucosidase by different cations and anions.
  • Analyzed the pH-dependence of kinetic parameters (k(cat)/K(m)) in the presence of varying salt concentrations.
  • Determined the impact of salt on apparent pK(a) values and the pH-independent catalytic rate constant.

Main Results:

  • Salts inhibit beta-glucosidase, with effectiveness varying by cation and anion type.
  • Inhibition is mainly due to salt-induced shifts in the enzyme's pK(a) values, altering the pH-activity profile.
  • The intrinsic catalytic rate constant ((k(cat)/K(m))(lim)) remains largely unaffected by salt concentration, ruling out significant reverse protonation contributions.

Conclusions:

  • Salt-induced pK(a) shifts are the primary mechanism of beta-glucosidase inhibition.
  • The study provides a method to assess the role of reverse protonation in other enzymes exhibiting salt-induced pK(a) shifts.